Grants and Contributions:
Title:
UKRI Biomanufacturing - 10100745 - Viral Enhancers - Development of small molecule formulations for enhanced production of AAV
Agreement Number:
1019804
Agreement Value:
$304,720.00
Agreement Date:
May 1, 2024 - Aug 31, 2025
Description:
As part of the international consortium project "Viral Enhancers - Development of small molecule formulations for enhanced production of AAV", this project will focus on developing and demonstrating at scale small molecule formulation(s) which increase the yield of next-generation gene therapies. Development of such technologies will enable faster clinical and commercial development of life saving technologies while simultaneously improving patient access through reduction of cost per dose.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Ottawa, Ontario, CA K1Z 5N4
Reference Number:
172-2024-2025-Q1-1019804
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
721336089
Recipient Type:
For-profit organization
Recipient's Operating Name:
Virica Biotech
Recipient's Legal Name:
Virica Biotech Inc.
Federal Riding Name:
Ottawa Centre
Federal Riding Number:
35075
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171